The journey from basic discoveries to clinical applications is often hampered by issues of reproducibility, predictability, and clinical relevance. Building robust in vitro and in vivo studies is essential for validating preclinical findings and ensuring their successful translation.

LAB-A-PORTER is committed to facilitating this by providing researchers globally with suitable reagents and tools. We support researchers on their preclinical research, from discovering drug targets and biomarkers to developing and testing in advanced in vitro and animal models, ultimately helping bridge the gap to clinical success. This week, we are going to introduce one of our trusted supplier, Reprocell, and their quality iPSCs.

Reprocell Stemgent: Human iPSCs 

Ready-to-use iPSCs are made using footprint-free StemRNA 3rd Gen Reprogramming Technology. No specialized reprogramming knowledge required.

StemRNA Human induced pluripotent stem cells (iPSCs) provide immediate access to the state-of-the-art Stemgent StemRNA 3rd Gen Reprogramming technology. These cells are ideal for validating the StemRNA 3rd Gen Technology with control cells prior to investing in reprogramming to develop patient-derived cell lines.

Benefits include:

Ready for use in experiments such as differentiation

• Reprogrammed using the state of the art StemRNA 3rd Gen Reprogramming Technology
• No retention or integration of reprogramming vectors
• Imunologically (ICC) and functionally (teratoma formation) pluripotent
• Normal karyotype

Significant time savings

• Saves 2-4 months or more compared to reprogramming
  your own iPSCs

Easy access to iPSCs for start-up labs

• No specialized reprogramming knowledge required
• Grows in standard stem cell media and support matrices